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Abstract
© 2018  Sokolov,  Bashirov,  Markosyan,  Povysheva,  Fadeev,  Izmailov,  Kuztetsov,  Safiullov,
Shmarov, Naroditskyi, Palotás and Islamov. Natural brain repair after stroke is extremely limited,
and current therapeutic options are even more scarce with no clinical break-through in sight.
Despite restricted regeneration in the central nervous system, we have previously proved that
human umbilical cord blood mono-nuclear cells (UCB-MC) transduced with adenoviral vectors
carrying  genes  encoding  vascular  endothelial  growth  factor  (VEGF),  glial  cell-derived
neurotrophic factor (GDNF), and neural cell  adhesion molecule (NCAM) successfully rescued
neurons in amyotrophic lateral sclerosis and spinal cord injury. This proof-of-principle project
was aimed at evaluating the beneficial effects of the same triple-gene approach in stroke. Rats
subjected to distal occlusion of the middle cerebral artery were treated intrathecally with a
combination of these genes either directly or using our cell-based (UCB-MC) approach. Various
techniques and markers were employed to evaluate brain injury and subsequent recovery after
treatment.  Brain  repair  was  most  prominent  when  therapeutic  genes  were  delivered  via
adenoviral vector- or UCB-MC-mediated approach. Remodeling of brain cortex in the stroke area
was confirmed by reduction of infarct volume and attenuated neural cell death, depletion of
astrocytes and microglial cells, and increase in the number of oligodendroglial cells and synaptic
proteins expression. These results imply that intrathecal injection of genetically engineered
UCB-MC over-expressing therapeutic molecules (VEGF, GDNF, and NCAM) following cerebral
blood vessel occlusion might represent a novel avenue for future research into treating stroke.
http://dx.doi.org/10.3389/fphar.2018.00111
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